Stock Comparison
ARGX vs BBIO
argenx NV ADR and BridgeBio Pharma Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$53.23B
$15.87B
P/E (TTM)
32.7
—
Forward P/E
30.4
—
Price/Sales
10.0
27.4
Price/Book
6.4
118.6
EV/EBITDA
27.6
-9.0
Dividend Yield
—
—
Profitability
Net Margin
30.44%
-102.70%
Operating Margin
27.34%
-80.17%
Return on Equity
23.60%
-1790.00%
Return on Assets
11.60%
-28.00%
Growth (YoY)
Revenue Growth
59.30%
66.80%
Earnings Growth
95.20%
0.00%
Price & Risk
Beta
-0.0
1.0
52-Week High
$939.68
$90.17
52-Week Low
$652.43
$47.29
Analyst Target
$1,085.78
$106.19
Compare ARGX and BBIO your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.